LabRoots and the Cell Biology Planning Committee are pleased to announce the 4th Annual Cell Biology Virtual Event, providing an opportunity to discuss recent discoveries in biological research, advancements in techniques, and tool developments in cell research.
Cell Biology 2020 Virtual Event will continue to create a valuable platform for inspiring global and interdisciplinary collaboration in a virtual environment, to study cells cells – their physiological properties, structure, the organelles they contain, environmental interactions, life cycle, division and death, on a microscopic and molecular level.
This years event will include the following tracks and topics:
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open 6 months from the date of the live event. The webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.
Like the 2019 conference, this event will be produced on our robust platform, allowing you to watch, learn and connect seamlessly across all desktop or mobile devices. Equipped with gamification and point system, you can now move around the entire event, earning points for a chance to win one of LabRoots' most popular T-shirts.
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2020 Cell Biology Virtual Event. Submission is free. Submit your abstract here.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.
Use #LRcellbio to follow the conversation!
POSTER SUBMISSION GUIDELINES
Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.
SUBMIT YOUR ABSTRACT
Enter the following information to this Submission Form:
All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.
If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.
Questions? Email Posters@LabRoots.com
Prof. Benedetta Bussolati obtained her medical degree at the University of Torino (Italy) and her PhD on Physiopathology of the Renal Insufficiency at the University of Parma (Italy). She currently holds the position of Associate Professor of Nephrology at the University of Torino and director of a Research group at the Molecular Biotechnology Centre. Dr. Bussolati has extensive experience in studies of stem cell biology and regenerative medicine that include characterization of various stem cell types and their potential use for tissue regeneration. She is actually focusing on the role extracellular vesicles as therapeutic tools for modulating tissue regeneration, angiogenesis and tumor vasculogenesis. She is founder and president of the Italian Society of Extracellular Vesicles (EVIta).
Steve Caplan received his PhD from the Lautenberg Center for Tumor and General Immunology at the Hebrew University Hadassah Medical Center, Jerusalem, Israel, in 1998. He trained as a postdoctoral fellow between 1998 and 2003 at the National Institutes of Health, before accepting a faculty position in the Department of Biochemistry and Molecular Biology at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska in 2003. Dr. Caplan is currently a Professor and Vice Chair for Administration, and serves as the Director of the UNMC Advanced Microscopy Core Facility, as well as the Research Institute-Program Coordinator for the Nebraska INBRE Program, an NIH-funded program designed to improve the research infrastructure for the state of Nebraska and to encourage and promote undergraduate science research. Dr. Caplan has received multiple awards, including Outstanding Faculty Mentor of Graduate Students, UNMC Distinguished Scientist and the Thomas Maciag award for mentorship and research. Dr. Caplan is the author of about 100 published manuscripts, as well as 4 novels of fiction that deal with the lives of scientists, and has written a series of articles for newspapers such as The Guardian in the UK.
Dr Hakim Djaballah holds a BSc degree from the University of Birmingham (England) and a doctorate degree from the University of Leicester (England). He is the co-founder, president & CEO of Keren Therapeutics, a startup company dedicated to the science of aging. Formerly, he was the CEO of the Pasteur Institute in South Korea, a translational research institute with a focus on infectious diseases and oncology. Dr Djaballah was affiliated with the Memorial Sloan Kettering Cancer Center (MSKCC) in New York, USA. He has over 25 year’s industrial and academic experience in drug discovery and development. Dr Djaballah is a molecular pharmacologist and technologist with expertise in infectious diseases & oncology, & a thought leader on drug discovery and development and sits on several national & international advisory boards. To date, he has published more than 96 articles, book chapters, and reviews. He is an inventor on a number of patents, a founder of two biotechnology companies, and the recipient of the 2007 Robots and Vision User Recognition Award.
Dr. Muller Fabbri is Associate Professor and co-Leader of the Cancer Biology Program at the University of Hawai’i Cancer Center (UHCC) in Honolulu, HI, USA. He also is the Scientific Lead of the Micro- and Nano-Scale Cancer Therapeutics Initiative at UHCC. Dr. Fabbri has provided the first evidence that microRNAs delivered to surrounding cells of the Tumor Microenvironment through extracellular vesicles can bind to Toll-like receptors and trigger downstream signaling pathways highly impactful on cancer biology. Dr. Fabbri is author of more than 90 peer reviewed publications, he has authored several book chapters, serves in the Editorial Board of many international scientific Journals. Dr. Fabbri’s lab is focused on studying how microRNAs (and other non-coding RNAs) are communicating between cancer cells and surrounding cells of the tumor microenvironment and how this affects cancer biology and the development of resistance to chemo and radiotherapy.
Mr. West, has been actively working in the field of medical device product development since earning his MS in biomedical product development from the University of Kansas (2011); a masters certificate in entrepreneurship from Nanyang Technological University in Singapore (2009) thanks to a scholarship from the Kauffman Foundation; and BS in mechanical engineering from the University of Kansas (2008). In addition to founding two companies he has worked in all aspects of medical product development from prototyping and proof of concept, through CAD, design and manufacturability. He has worked in production, served as head of regulatory, and developed quality management systems that comply with the requirements of ISO-13485:2016 and cGMP. He's a natural problem solver and works at the intersection of business and engineering.
Eppendorf is a leading life science company that develops and sells instruments, consumables, and services for liquid-, sample-, and cell handling. Its product range includes pipettes and automated pipetting systems, centrifuges, mixers, spectrometers, and DNA amplification ...See more See less
Sony Biotechnology Inc. is dedicated to helping researchers working across different life science disciplines to achieve the best scientific results. By leveraging Sony's vast know-how in electronics innovation and design we offer next-generation cell analysis systems to ...See more See less
LI-COR first introduced scientific instruments for plant science research and quickly grew to provide scientists tools for such diverse disciplines as atmospheric research and the study of how proteins interact at the cellular level. LI-COR Biosciences is a global leader in the ...See more See less
Manuscriptedit specializes in providing services in Scientific & English editing, proofreading, medical writing, academic writing, formatting and publication support. Within a short span of time, the company has grown rapidly to be counted among the world's leading service ...See more See less
With a portfolio of more than 4,000 products covering the fields of genomics, protein analysis and expression, cellular analysis, drug discovery and genetic identity, Promega is a global leader in providing innovative solutions and technical support to life scientists in ...See more See less
The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here
Dr. Aguilar obtained his PhD degree in Immunochemistry from the School of Pharmacy and Biochemistry, University of Buenos Aires, Argentina. Dr. Aguilar pursued his post-doctoral training at the National institutes of Health in Bethesda, MD in the lab of the well-known cell ...See more See less
Matt entered the research field over 20 years ago as a lab animal technician at the TSI/Mason contract research facility. He has worked at both contract facilities such as TSI and OREAD Biosafety as well in industry at Pharmacia, Pfizer, and Sanofi-Aventis. During that period he ...See more See less
Dr. Laura Perin is an Assistant Professor at the Keck School of Medicine, University of Southern California. Dr Perin obtained a master's degree in Biological Sciences at the University of Padova, Italy in 2000 and a Ph.D. in Stem cells and Tissue Engineering at the Harvard ...See more See less
Leading Novabiosis' primary cell business, Matthew brings to the Company a skill for implementing sales-driven business strategies, an extensive track record of meeting and surpassing targeted sales objectives, and a passion for translating customer needs into solutions that ...See more See less
|Operating System||Internet Explorer||Firefox||Chrome||Safari|
|Windows 7||IE8+||FF10+||Chrome15+||Windows 8||IE10||FF10+||Chrome15+|
|Mac OS X||FF10+||Chrome15+||Safari5.1+|
- For viewing Webinars:
- For viewing Virtual Events